Progressive Care Past Earnings Performance
Past criteria checks 0/6
Progressive Care's earnings have been declining at an average annual rate of -42.4%, while the Consumer Retailing industry saw earnings growing at 14% annually. Revenues have been growing at an average rate of 5.9% per year.
Key information
-42.4%
Earnings growth rate
-25.1%
EPS growth rate
Consumer Retailing Industry Growth | 10.9% |
Revenue growth rate | 5.9% |
Return on equity | -73.1% |
Net Margin | -29.5% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Progressive Care makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 50 | -15 | 14 | 0 |
30 Sep 23 | 33 | 1 | 10 | 0 |
30 Jun 23 | 31 | -8 | 9 | 0 |
31 Mar 23 | 42 | -5 | 13 | 0 |
31 Dec 22 | 41 | -6 | 12 | 0 |
30 Sep 22 | 40 | -12 | 11 | 0 |
30 Jun 22 | 40 | -2 | 10 | 0 |
31 Mar 22 | 39 | -1 | 11 | 0 |
31 Dec 21 | 39 | 0 | 11 | 0 |
30 Sep 21 | 39 | 0 | 11 | 0 |
30 Jun 21 | 40 | 0 | 11 | 0 |
31 Mar 21 | 39 | -1 | 11 | 0 |
31 Dec 20 | 39 | -1 | 10 | 0 |
30 Sep 20 | 39 | -2 | 10 | 0 |
30 Jun 20 | 39 | -2 | 10 | 0 |
31 Mar 20 | 36 | -2 | 10 | 0 |
31 Dec 19 | 33 | -3 | 9 | 0 |
31 Dec 18 | 21 | -2 | 6 | 0 |
Quality Earnings: RXMD is currently unprofitable.
Growing Profit Margin: RXMD is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RXMD is unprofitable, and losses have increased over the past 5 years at a rate of 42.4% per year.
Accelerating Growth: Unable to compare RXMD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: RXMD is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (14.4%).
Return on Equity
High ROE: RXMD has a negative Return on Equity (-73.09%), as it is currently unprofitable.